Expanding Business Horizons: URENET Advertising Group Ventures into Medical Advertising Support

Expansion of Business Domain

URENET Advertising Group Inc., headquartered in Fukuoka, Japan, led by CEO Leo Kato, has officially announced the initiation of its support for medical and clinic-related advertising. This expansion bridges the gap from their established expertise in health products and cosmetics, transitioning into new opportunities in AGA (androgenetic alopecia) treatment and beauty telemedicine.

Background of the Expansion

As a well-known player in the D2C (Direct-to-Consumer) sector, URENET has successfully leveraged its core strengths in health foods and cosmetics. Recently, they have broadened their scope to include everyday goods like watches, razors, and beauty devices. With this new initiative, they aim to apply their established operational model to the medical field, thereby diversifying their business portfolio.

At the heart of this initiative is a robust operational framework that focuses on designing compelling messages, performing creative verifications through a rapid PDCA cycle, and optimizing media strategies. URENET can now operate across various major advertising platforms, including Meta, TikTok, LINE, Pinterest, X (formerly Twitter), and YouTube, enabling seamless and effective advertising across channels.

Newly Launched Areas of Focus

Examples of the medical advertising services URENET will provide include:

- AGA Treatment: Providing advertising support for both online consultations and in-person visit facilitation.
- Beauty Online Doctor Consultations: Focusing on advertisements related to vitamin intake, skin whitening, and skin texture improvement through prescription design.

It’s essential to clarify that this announcement does not communicate any medical efficacy or effectiveness claims. Each specific advertising expression will be managed according to relevant laws and media guidelines.

Operational Policies: Tailored Creative and Review Processes

To ensure compliance with legal and guideline standards such as the Medical Care Act, Medical Advertising Guidelines, Pharmaceutical Affairs Law, and Personal Information Protection Law, URENET will implement structured review processes. This includes appropriate evaluations by medical institutions and reviewers to guarantee the quality and compliance of all advertising content.

Media Review Compliance

The company has also standardized processes related to the submission, amendment, and use of supporting documentation in accordance with each media outlet's medical-related policies.

Creative Management

Guidelines governing the use of case expressions, testimonials, and comparative expressions will ensure safety and transparency. Furthermore, URENET will conduct parallel validations of both short videos and static images to quickly identify winning patterns in their advertising strategies.

Measurement Strategy

To optimize indicators such as reach, view completion rates, click-through rates, and conversion rates iteratively, URENET will manage the balance of frequency, reach, and acquisition efficiency across all media platforms.

Future Outlook: Diversification and Growth Model Enhancement

By entering the medical and clinic sectors after expanding into everyday goods, URENET is set to further diversify its D2C project portfolio. Leveraging its comprehensive media capabilities and a reproducible operational model, the company aims to achieve a balance between profitability and growth, thereby maximizing corporate value over the medium to long term.

This exciting venture marks a new chapter for URENET Advertising Group as they move boldly into the healthcare advertising domain. With their rich expertise and strategic approach, they are well-positioned to capture new market opportunities and deliver tailored solutions to their clients in the medical field.